Kamada Ltd. - stock earnings
KMDA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 5.1 million USD | 38.4 million USD |
| 2023Q3 | 3.2 million USD | 37.9 million USD |
| 2023Q2 | 1.8 million USD | 37.4 million USD |
| 2023Q1 | -1.8 million USD | 30.7 million USD |
| 2022Q4 | -1.8 million USD | 30.7 million USD |
| 2022Q3 | 484000 USD | 32.2 million USD |
| 2022Q2 | -3.9 million USD | 23.6 million USD |
| 2022Q1 | -1.8 million USD | 28.1 million USD |
| 2021Q4 | -5.0 million USD | 31.5 million USD |
| 2021Q3 | -845000 USD | 23.0 million USD |
| 2021Q2 | 937000 USD | 24.2 million USD |
| 2021Q1 | 2.7 million USD | 24.9 million USD |
| 2020Q4 | 1.6 million USD | 31.5 million USD |
| 2020Q3 | 6.8 million USD | 35.3 million USD |
| 2020Q2 | 3.5 million USD | 33.1 million USD |
| 2020Q1 | 5.2 million USD | 33.3 million USD |
| 2019Q4 | 5.4 million USD | 32.1 million USD |
| 2019Q3 | 5.8 million USD | 33.1 million USD |
| 2019Q2 | 6.1 million USD | 35.3 million USD |
| 2019Q1 | 4.9 million USD | 26.8 million USD |
| 2018Q4 | 17.7 million USD | 48.2 million USD |
| 2018Q3 | -2.4 million USD | 15.0 million USD |
| 2018Q2 | 5.7 million USD | 33.8 million USD |
| 2018Q1 | 1.3 million USD | 17.4 million USD |
| 2017Q4 | 6.3 million USD | 35.7 million USD |
| 2017Q3 | -236000 USD | 22.9 million USD |
| 2017Q2 | 4.9 million USD | 32.5 million USD |
| 2017Q1 | -4.0 million USD | 11.6 million USD |
| 2016Q4 | -1.8 million USD | 24.3 million USD |
| 2016Q3 | -1.0 million USD | 19.4 million USD |
| 2016Q2 | -1.6 million USD | 19.1 million USD |
| 2016Q1 | -2.3 million USD | 14.8 million USD |
| 2015Q4 | 988000 USD | 25.9 million USD |
| 2015Q3 | -4.6 million USD | 16.1 million USD |
| 2015Q2 | -2.3 million USD | 19.2 million USD |
| 2015Q1 | 1.7 million USD | 25.8 million USD |
| 2014Q4 | 1.2 million USD | 24.9 million USD |
| 2014Q3 | -2.9 million USD | 17.2 million USD |
| 2014Q2 | -8.4 million USD | 15.8 million USD |
| 2014Q1 | -3.1 million USD | 13.2 million USD |
| 2013Q4 | 1.6 million USD | 24.4 million USD |
| 2013Q3 | 37000 USD | 17.5 million USD |
| 2013Q2 | 890000 USD | 16.1 million USD |
| 2013Q1 | -2.0 million USD | 12.6 million USD |
| 2012Q4 | 2.9 million USD | 21.6 million USD |
| 2012Q3 | 103000 USD | 17.7 million USD |
| 2012Q2 | -2.2 million USD | 13.8 million USD |
| 2012Q1 | -472000 USD | 19.6 million USD |
| 2011Q4 | 455000 USD | 21.2 million USD |
| 2011Q3 | ? USD | 13.3 million USD |
| 2011Q2 | ? USD | 12.4 million USD |
| 2011Q1 | ? USD | 12.7 million USD |
KMDA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 8.3 million USD | 144.8 million USD |
| 2022 | -2.3 million USD | 129.3 million USD |
| 2021 | -2.2 million USD | 103.6 million USD |
| 2020 | 17.1 million USD | 133.2 million USD |
| 2019 | 22.3 million USD | 127.2 million USD |
| 2018 | 22.3 million USD | 114.5 million USD |
| 2017 | 6.9 million USD | 102.8 million USD |
| 2016 | -6.7 million USD | 77.5 million USD |
| 2015 | -11.3 million USD | 70.1 million USD |
| 2014 | -12.6 million USD | 71.9 million USD |
| 2013 | 443000 USD | 70.6 million USD |
| 2012 | 260000 USD | 72.7 million USD |
| 2011 | -3.5 million USD | 55.9 million USD |
| 2010 | -15.2 million USD | 36.3 million USD |
| 2009 | -22.0 million USD | 15.0 million USD |
| 2008 | -12.4 million USD | 15.2 million USD |
| 2007 | -22.9 million USD | 13.4 million USD |
KMDA
Price: $5.15
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.15 USD
P/E Ratio: 46.08
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 40400
Ebitda: 7.4 millionMarket Capitalization: 311.6 million